Every protocol we coordinate is grounded in peer-reviewed research and guided by a team of scientific researchers and licensed medical professionals — with collective expertise across biotechnology, cellular technologies, immunology, regenerative medicine, and orthopedics.
By Jed Ryan, Founder and CEO · Reviewed by Adas Darinskas, PhD, Chief Science Officer · Published · Last reviewed
We believe clients deserve access to treatments that are both innovative and scientifically validated. Every therapy we coordinate has a clear scientific rationale grounded in published research, and we are transparent about where the evidence is robust, where it is emerging, and where it is still developing.
Strong Craft Regen operates within a broader scientific and medical network, consulting regularly with collaborating physicians, PhD researchers, and the clinical team at Innovita Clinic. Every protocol reflects the combined input of scientific leadership and licensed medical administration.
MSC therapy is one of the most extensively studied areas in regenerative medicine. Research has demonstrated their efficacy in modulating immune responses, reducing inflammation, promoting tissue repair, and supporting neurological recovery. Key mechanisms include paracrine signalling, immunosuppression, and direct differentiation into target cell types.
Exosome research has accelerated dramatically over the past decade. Studies have demonstrated their ability to cross the blood-brain barrier, deliver therapeutic cargo to target cells, modulate immune responses, and promote tissue regeneration — making them one of the most promising frontiers in modern medicine.
Peptide science has produced hundreds of published studies documenting the efficacy and safety of specific peptides for tissue repair, anti-aging, immune modulation, hormonal optimisation, and cognitive enhancement. Their high specificity and low toxicity profile make them an ideal precision medicine tool.
Strong Craft Regen works with a coordinated group of Vilnius-based operations spanning research, manufacturing, and clinical care. Reverse Body Time is the integrated research and partnership arm, co-founded by Dr. Adas Darinskas. Froceth is the GMP cellular manufacturing and cellular research entity, with a new GMP facility scheduled to come online in 2026. Innovita Clinic is the licensed medical facility where all treatments are administered. Together, they form one of the most tightly coordinated research-to-clinic operations in European regenerative medicine.
Beyond Vilnius, Strong Craft Regen also maintains partnerships with clinics across Europe — with a growing worldwide network — enabling us to coordinate access to regenerative care at additional qualified facilities when appropriate for a client's needs.
Visit Reverse Body Time